Vinci Gen S.A. (WSE:VGN)

Market Cap	3.12M
Revenue (ttm)	52.62K
Net Income (ttm)	69.77K
Shares Out	10.75M
EPS (ttm)	0.01
PE Ratio	44.68
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,021
Average Volume	14,661
Open	0.3060
Previous Close	0.2940
Day's Range	0.2840 - 0.3080
52-Week Range	0.2280 - 1.1850
Beta	0.34
RSI	47.86
Earnings Date	Mar 20, 2026

About Vinci Gen

Vinci Gen S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. Vinci Gen S.A. was formerly known as Movie Games VR Spólka Akcyjna and changed its name to Vinc...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: VGN

Financial Performance

In 2023, Vinci Gen's revenue was 20,000, a decrease of -61.54% compared to the previous year's 52,000. Losses were -60,127, -65.56% less than in 2022.